Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... According to a study from the United States, "The herpes simplex virus (HSV) ICP0 protein acts to overcome intrinsic cellular defenses that ... protein (PML), a component of host nuclear domain 10s." "While varicella-zoster virus is also insensitive to interferon, ORF61p, its ICP0 ortholog, failed to degrade ...
2009 NOV 9 ... its clinical-stage nucleoside analogue in Phase II development for the treatment of herpes zoster (shingles). The Company has also licensed the use of its proprietary MSCRAMM® ...
2009 NOV 28 ... website at http://www.inhibitex.com. About Shingles and FV-100 Shingles, also known as herpes zoster, is an infection caused by the reactivation of varicella zoster virus (VZV), the same ...
2009 NOV 9 ... According to a study from Munich, Germany, "Acute herpes zoster is a prevalent condition. One of its major symptoms is pain, which can highly influence ...
2009 OCT 12 ... population-based study to assess health care utilization (HCU) and costs associated with herpes zoster (HZ) and Its complications, Including postherpetic neuralgia (PHN) and nonpain ...
2009 OCT 19 ... Tb4 eye drops) in the management of chronic non-healing corneal ulcers caused by the herpes zoster virus. He reported on four patients who ranged in age from 47-84, all of whom had ...
2009 NOV 2 ... in two patients; the causative species of NBM were enterovirus in one episode, herpes simplex virus 1 in four (compared with the younger group, P< 0.05), and varicella ... simplex virus 1 in four (compared with the younger group, P< 0.05), and varicella zoster virus in one. The prevalence of BM was higher in the older group than in the younger," ...
2009 OCT 19 ... varicella-zoster virus (VZV) specific humoral and cell-mediated immunity (CMI) to herpes zoster (HZ) and protection against HZ morbidity and to compare immune responses to HZ and ...
2009 NOV 2 ... vasculopathy. Prompt diagnosis and treatment are critical to minimize morbidity in herpes zoster as well as morbidity and death in VZV vasculitis and encephalitis. Detection of anti-VZV ...
2009 NOV 17 ... of human trigeminal ganglia latently infected with two pathogenic alphaherpesviruses, herpes simplex virus 1 (HSV-1) and varicella-zoster virus (VZV), confirmed the expression of ...
2009 NOV 16 ... 1.11-1.24), influenza (OR=1.10; 1.01-1.19), cellulitis (OR=1.08; 1.02-1.14) and herpes zoster (OR=1.26; 1.15-1.37). Associations with pneumonia and cellulitis remained significant ...
2009 NOV 9 ... to detect HCMV and EBV. Sera were tested for anti-HCMV and EBV IgG antibodies. PCRs for herpes simplex (HSV) and varicella zoster virus (VZV) were performed in subgingival samples ...
2009 OCT 5 ... without TAC (p = 0.04). One patient temporally discontinued the treatment because of herpes zoster. In RA patients with inadequate response to MTX and a TNF inhibitor, additions of low ...
